Stockhead TV
Stockhead’s Sarah Hughan sits down with LTR Pharma’s (ASX:LTP) executive chairman Lee Rodne to get the short end of the long story on the company’s latest news.
The health company’s erectile dysfunction spray, Spontan, has been given to the first group of patients under a Government scheme in a major step forward in its market introduction strategy.
The rollout allows medical practitioners to prescribe it to a broader class of patients, streamlining access.
Tune in to hear LTR Pharma’s Lee Rodne on why Spontan is hot right now, its global potential, and more.
This video was developed in collaboration with LTR Pharma , a Stockhead advertiser at the time of publishing.
The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.
Health & Biotech
Health & Biotech
Health & Biotech
